Evidence map›Paper›PMID 32831622›Full record

ArticleBiochemical engineering journal2019

Direct measurement of deubiquitinating enzyme activity in intact cells using a protease-resistant, cell-permeable, peptide-based reporter.

Nora Safa, Jacob H Pettigrew, Ted J Gauthier, Adam T Melvin

Open access · greenAbstract read
In one paragraph

Article in Biochemical engineering journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Cytosolic Delivery of Functional Ubiquitin.Journal of peptide science : an official publication of the European Peptide Society · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Assay Systems for Profiling Deubiquitinating Activity.International journal of molecular sciences · 2020
    Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nora SafaCain Department of Chemical Engineering, Louisiana State University, Baton Rouge, LA, 70803.
Jacob H PettigrewCain Department of Chemical Engineering, Louisiana State University, Baton Rouge, LA, 70803.
Ted J GauthierLSU AgCenter Biotechnology Lab, Louisiana State University, Baton Rouge, LA, 70803.
Adam T MelvinCain Department of Chemical Engineering, Louisiana State University, Baton Rouge, LA, 70803.
Louisiana State University · US

Funding

Ex vivo analysis of deubiquitinating enzyme activity in single multiple myeloma cellsR03EB020935 · NIBIB · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI MELVIN, ADAM THOMAS · 2015 to 2016
$140k
NIBIB NIH HHS R03 EB020935
6 · The paper itself

Abstract

Deubiquitinating enzymes (DUBs) regulate the removal of the polyubiquitin chain from proteins targeted for degradation. Current approaches to quantify DUB activity are limited to test tube-based assays that incorporate enzymes or cell lysates, but not intact cells. The goal of this work was to develop a novel peptide-based biosensor of DUB activity that is cell permeable, protease-resilient, fluorescent, and specific to DUBs. The biosensor consists of an N-terminal β-hairpin motif that acts as both a 'protectide' to increase intracellular stability and a cell penetrating peptide (CPP) to facilitate the uptake into intact cells. The β-hairpin was conjugated to a C-terminal substrate consisting of the last four amino acids in ubiquitin (LRGG) to facilitate DUB mediated cleavage of a C-terminal fluorophore (AFC). The kinetics of the peptide reporter were characterized in cell lysates by dose response and inhibition enzymology studies. Inhibition studies with an established DUB inhibitor (PR-619) confirmed the specificity of both reporters to DUBs. Fluorometry and fluorescent microscopy experiments followed by mathematical modeling established the capability of the biosensor to measure DUB activity in intact cells while maintaining cellular integrity. The novel reporter introduced here is compatible with high-throughput single cell analysis platforms such as FACS and droplet microfluidics facilitating direct quantification of DUB activity in single intact cells with direct application in point-of-care cancer diagnostics and drug discovery.

Indexed as

Cell penetrating peptidesDeubiquitinating enzymes (DUBs)FluorometryPeptide-based biosensorsProtease-resilient peptidesSingle cell analysis

Identifiers

PMID32831622
PMCPMC7442178
OpenAlexW2964977124

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.